STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement

STAAR Surgical (NASDAQ:STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of Shinjuku LASIK Clinic in Tokyo, today announced they have entered into a multi-year Strategic Cooperation Agreement to provide STAAR’s EVO Visian ICL intraocular lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive eye treatment.

As quoted in the press release:

“I am very proud that my clinic has now joined with STAAR Surgical Company as an official strategic partner to provide STAAR’s ICL as a primary and premium option for patients wanting to experience high quality vision,” stated Dr. Maro Kariya, General Manager of Shinjuku LASIK Clinic. “Our clinic already has several certified ICL surgeons on staff and we look forward to growing and working even more closely with STAAR to achieve our shared goal of providing excellent visual results to patients,” concluded Dr. Kariya.

Caren Mason, President & CEO of STAAR, stated, “Shinjuku LASIK Clinic is a leading provider of refractive surgery in Japan and has demonstrated its commitment to STAAR’s EVO Visian ICL family of lenses by significantly increasing their use of the ICL in recent months. The clinic positions the ICL as a premium option for patients including those with lower-diopter refractive error.Staff members who have had ICL surgery are very happy with their visual freedom results and have positioned the ICL on their website as the primary procedure.This strategic cooperation agreement with Shinjuku LASIK Clinic expands our relationship with growth commitments by the clinic and co-marketing support and certified surgeon and staff training by STAAR.”

Click here to read the full press release.